Discovery and antiparasitic activity of AZ960 as a Trypanosoma brucei ERK8 inhibitor
- 1 October 2016
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 24 (19) , 4647-4651
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Discovery of Inhibitors of Trypanosoma brucei by Phenotypic Screening of a Focused Protein Kinase LibraryChemMedChem, 2015
- New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open ResourceScientific Reports, 2015
- Regulators of Trypanosoma brucei Cell Cycle Progression and Differentiation Identified Using a Kinome-Wide RNAi ScreenPLOS Pathogens, 2014
- Estimating and Mapping the Population at Risk of Sleeping SicknessPLOS Neglected Tropical Diseases, 2012
- High‐Throughput Analysis of an RNAi Library Identifies Novel Kinase Targets in Trypanosoma bruceiChemical Biology & Drug Design, 2011
- A chromatin-bound kinase, ERK8, protects genomic integrity by inhibiting HDM2-mediated degradation of the DNA clamp PCNAJournal of Cell Biology, 2010
- The cell cycle as a therapeutic target against Trypanosoma brucei: Hesperadin inhibits Aurora kinase‐1 and blocks mitotic progression in bloodstream formsMolecular Microbiology, 2009
- The Burden of Human African TrypanosomiasisPLOS Neglected Tropical Diseases, 2008
- Discovery of Trypanocidal Compounds by Whole Cell HTS of Trypanosoma bruceiChemical Biology & Drug Design, 2006
- Antigenic variation in Trypanosoma brucei: facts, challenges and mysteriesCurrent Opinion in Microbiology, 2004